[go: up one dir, main page]

YU2997A - Derivati triazola korisni u terapiji - Google Patents

Derivati triazola korisni u terapiji

Info

Publication number
YU2997A
YU2997A YU2997A YU2997A YU2997A YU 2997 A YU2997 A YU 2997A YU 2997 A YU2997 A YU 2997A YU 2997 A YU2997 A YU 2997A YU 2997 A YU2997 A YU 2997A
Authority
YU
Yugoslavia
Prior art keywords
therapy
triazole derivatives
derivatives useful
useful
compounds
Prior art date
Application number
YU2997A
Other languages
English (en)
Inventor
Stuart Green
Peter Stephenson
Charles W. Murtiashaw
Original Assignee
Pfizer Research And Development Company N.V./S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Research And Development Company N.V./S.A. filed Critical Pfizer Research And Development Company N.V./S.A.
Publication of YU2997A publication Critical patent/YU2997A/sh
Publication of RS49526B publication Critical patent/RS49526B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C07F9/6518—Five-membered rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Pronalazak daje jedinjenja formule I: R1-OP(O)(OH)2 gde R1 predstavlja ne-hidroksi deo jednog protivgljivičnog jedinjenja koje sadrži jednu tercijarnu hidroksi grupu; ili jednu njegovu farmaceutski prihvatljivu so. Jedinjenja prema pronalasku korisna su kod lečenja gljivičnih infekcija i imaju dobru rastvorljivost u vodi.
YU2997A 1996-02-02 1997-01-28 Derivati triazola korisni u terapiji RS49526B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9602080.5A GB9602080D0 (en) 1996-02-02 1996-02-02 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
YU2997A true YU2997A (sh) 2000-10-30
RS49526B RS49526B (sr) 2006-12-15

Family

ID=10787975

Country Status (42)

Country Link
US (4) US6790957B2 (sh)
EP (1) EP0880533B1 (sh)
JP (1) JP2959846B2 (sh)
KR (1) KR100283546B1 (sh)
CN (1) CN1085213C (sh)
AP (1) AP678A (sh)
AT (1) ATE219089T1 (sh)
AU (1) AU709781B2 (sh)
BG (1) BG63946B1 (sh)
BR (1) BR9707257A (sh)
CA (1) CA2240777C (sh)
CO (1) CO4761066A1 (sh)
CZ (1) CZ291431B6 (sh)
DE (1) DE69713284T2 (sh)
DK (1) DK0880533T3 (sh)
DZ (1) DZ2172A1 (sh)
ES (1) ES2175336T3 (sh)
GB (1) GB9602080D0 (sh)
GT (1) GT199700016A (sh)
HN (1) HN1997000012A (sh)
HR (1) HRP970063B1 (sh)
HU (1) HU226133B1 (sh)
ID (1) ID15858A (sh)
IL (3) IL124865A (sh)
IS (1) IS1995B (sh)
MY (1) MY116849A (sh)
NO (1) NO323771B1 (sh)
NZ (1) NZ330654A (sh)
OA (1) OA10711A (sh)
PL (1) PL187237B1 (sh)
PT (1) PT880533E (sh)
RS (1) RS49526B (sh)
RU (1) RU2176244C2 (sh)
SA (1) SA97170578B1 (sh)
SI (1) SI0880533T1 (sh)
SK (1) SK283136B6 (sh)
TN (1) TNSN97023A1 (sh)
TR (1) TR199801440T2 (sh)
TW (1) TW434247B (sh)
UA (1) UA46828C2 (sh)
WO (1) WO1997028169A1 (sh)
ZA (1) ZA97826B (sh)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
DE19751525C2 (de) 1997-11-20 2003-02-13 Bat Cigarettenfab Gmbh Verfahren und Vorrichtung zur Regelung der Ausgangsfeuchte von Tabak
US6265584B1 (en) 1998-05-22 2001-07-24 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
WO2000030655A1 (en) 1998-11-20 2000-06-02 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6235728B1 (en) 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
KR20010050557A (ko) 1999-09-29 2001-06-15 타이도 나오카타 아졸 유도체 또는 그의 염
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
US7540402B2 (en) * 2001-06-29 2009-06-02 Kva, Inc. Method for controlling weld metal microstructure using localized controlled cooling of seam-welded joints
US7323572B2 (en) 2002-07-16 2008-01-29 Pfizer Inc Process for controlling the hydrate mix of a compound
WO2005006860A2 (en) * 2003-07-18 2005-01-27 The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations Azole derivatives and methods for making the same
KR20070085093A (ko) * 2004-03-24 2007-08-27 파스젠, 엘엘씨. Ａｍｐ-활성화 단백질 키나아제의 약리학적 저해에 의한신규한 신경 보호 방법
CN1303073C (zh) * 2005-05-31 2007-03-07 中国人民解放军第二军医大学 取代三唑酮苄胺三唑醇类抗真菌化合物及其制备方法
ES2432360T3 (es) * 2005-12-20 2013-12-03 Eisai R&D Management Co., Ltd. Procedimiento para la producción de profármaco de azol soluble en agua
ES2533007T3 (es) 2005-12-27 2015-04-06 Otsuka Pharmaceutical Co., Ltd. Compuesto de benzoacepina soluble en agua y su composición farmacéutica
ES2351365T3 (es) * 2006-02-22 2011-02-03 EISAI R&D MANAGEMENT CO., LTD. Composición farmacéutica estabilizada.
KR100889937B1 (ko) * 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
US20110123627A1 (en) * 2008-04-15 2011-05-26 Larry Yun Fang High density compositions containing posaconazole and formulations comprising the same
CN101575330B (zh) * 2008-05-05 2012-10-31 丽珠医药集团股份有限公司 伏立康唑广谱抗真菌药物化合物、其组合物及用途
WO2011064558A2 (en) 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
EP2723452A2 (en) 2011-06-22 2014-04-30 Vyome Biosciences Pvt Ltd Conjugate-based antifungal and antibacterial prodrugs
EP2561863A1 (en) 2011-08-22 2013-02-27 Farmaprojects, S.A.U. Pharmaceutical compositions comprising voriconazole
ES2774267T3 (es) * 2012-01-20 2020-07-20 Mycovia Pharmaceuticals Inc Compuestos inhibidores de metaloenzimas
SMT202300324T1 (it) * 2012-03-19 2023-11-13 Cidara Therapeutics Inc Regimi di dosaggio per composti della classe delle echinocandine
CN103864844B (zh) * 2012-12-09 2016-10-05 正大天晴药业集团股份有限公司 一种福司氟康唑的制备方法
CN103304600B (zh) * 2013-03-04 2018-05-25 陕西合成药业股份有限公司 一种伏立康唑磷酸酯三水合物及其制备方法和用途
US20140275122A1 (en) 2013-03-14 2014-09-18 Fresenius Kabi Usa, Llc Voriconazole Formulations
RU2719579C2 (ru) * 2013-03-14 2020-04-21 Сидара Терапьютикс, Инк. Режимы дозирования для соединений класса эхинокандинов
MX2015016675A (es) 2013-06-04 2016-07-15 Vyome Biosciences Pvt Ltd Particulas recubiertas y composiciones que comprenden las mismas.
CN103524560A (zh) * 2013-09-28 2014-01-22 陕西合成药业有限公司 伏立康磷酸酯钠水合物及其多晶型
CN104650140B (zh) * 2013-11-18 2017-11-10 正大天晴药业集团股份有限公司 一种高纯度福司氟康唑的制备方法
AU2015212312A1 (en) 2014-01-29 2016-08-18 Vyome Therapeutics Limited Treatments for resistant acne
CN104860992A (zh) * 2014-02-25 2015-08-26 陕西合成药业股份有限公司 一种高纯度福司氟康唑制备方法
CN105985377A (zh) * 2015-02-09 2016-10-05 陕西合成药业股份有限公司 一种福司氟康唑盐水合物及其制备方法
CN106279280A (zh) * 2015-05-25 2017-01-04 西藏卫信康医药股份有限公司 一种化合物及其制备方法和应用
CN106518922A (zh) * 2015-09-12 2017-03-22 陕西合成药业股份有限公司 一种三唑类化合物及其制备方法和用途
CN106546668A (zh) * 2015-09-22 2017-03-29 陕西合成药业股份有限公司 一种分离福司氟康唑或其药用盐有关物质的hplc方法
CN105237569B (zh) * 2015-10-21 2017-07-25 西南科技大学 一种制备2，4‑二氟‑α，α‑二（1氢‑1，2，4‑三唑‑1‑基甲基）苯甲醇磷酸二苄酯的合成方法
CN105753902B (zh) * 2016-04-11 2017-08-25 浙江诚意药业股份有限公司 一种福司氟康唑的制备方法
CN108676031A (zh) * 2018-05-29 2018-10-19 重庆威鹏药业有限公司 水溶性三唑类抗真菌膦酸化合物及其制备方法和应用
CN111171075B (zh) * 2020-04-03 2022-07-12 北京四环生物制药有限公司 一种福司氟康唑的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4528284A (en) * 1982-10-15 1985-07-09 Ciba-Geigy Corporation Fungicidal 2-(azolylmethyl-1'-yl)-2-aryl-2-(cyano, alkoxycarbonyl, alkylthiocarbonyl and aminocarbonyl)-2-phosphorus acid esters
US4952232A (en) * 1987-04-29 1990-08-28 E. I. Du Pont De Nemours And Company Antifungal carbinols
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
TW211006B (sh) * 1990-08-24 1993-08-11 Mochida Pharm Co Ltd
TW218017B (sh) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
US5358939A (en) * 1992-06-25 1994-10-25 Rohm And Haas Company Fungicidal 2-aryl-2,2-disubstituted ethyl-1,2,4-triazoles
WO1995019983A1 (en) * 1994-01-24 1995-07-27 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
AU682580B2 (en) * 1994-02-25 1997-10-09 Takeda Chemical Industries Ltd. Injectable emulsions containing antifungal triazole derivatives
GB9512961D0 (en) * 1995-06-26 1995-08-30 Pfizer Ltd Antifungal agents
FR2741061B1 (fr) * 1995-11-13 1998-03-20 Alcatel Fibres Optiques Procede de fabrication d'une fibre optique monomode et amplificateur optique utilisant une telle fibre
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
US5767977A (en) * 1996-12-19 1998-06-16 Hewlett-Packard Co. Method and apparatus for a carriage latch and power cord lock-out system for an optical scanner

Also Published As

Publication number Publication date
SK283136B6 (sk) 2003-03-04
DK0880533T3 (da) 2002-07-15
BG63946B1 (bg) 2003-07-31
HK1018217A1 (en) 1999-12-17
PT880533E (pt) 2002-09-30
HRP970063A2 (en) 1998-06-30
ID15858A (id) 1997-08-14
DE69713284T2 (de) 2003-03-27
KR19990082233A (ko) 1999-11-25
CN1210540A (zh) 1999-03-10
OA10711A (en) 2001-06-04
WO1997028169A1 (en) 1997-08-07
US20040236105A1 (en) 2004-11-25
UA46828C2 (uk) 2002-06-17
RU2176244C2 (ru) 2001-11-27
PL187237B1 (pl) 2004-06-30
IL124865A (en) 2002-03-10
DE69713284D1 (de) 2002-07-18
HUP9900949A3 (en) 2001-08-28
RS49526B (sr) 2006-12-15
US20050130940A1 (en) 2005-06-16
JPH10512599A (ja) 1998-12-02
AP9700923A0 (en) 1997-01-31
TR199801440T2 (xx) 1998-10-21
DZ2172A1 (fr) 2002-12-01
PL328436A1 (en) 1999-02-01
BR9707257A (pt) 1999-04-06
CA2240777C (en) 2002-06-11
JP2959846B2 (ja) 1999-10-06
SI0880533T1 (en) 2002-08-31
GT199700016A (es) 1998-07-24
HUP9900949A2 (hu) 2001-05-28
IL133135A0 (en) 2001-03-19
CZ242098A3 (cs) 1999-05-12
EP0880533A1 (en) 1998-12-02
ZA97826B (en) 1998-07-31
CZ291431B6 (cs) 2003-03-12
US20070027115A1 (en) 2007-02-01
IS4785A (is) 1998-06-26
NO983560L (no) 1998-08-03
ES2175336T3 (es) 2002-11-16
KR100283546B1 (ko) 2001-04-02
TNSN97023A1 (fr) 2005-03-15
CN1085213C (zh) 2002-05-22
HRP970063B1 (en) 2001-12-31
IL133135A (en) 2003-07-06
TW434247B (en) 2001-05-16
BG102603A (en) 1999-03-31
AU709781B2 (en) 1999-09-09
EP0880533B1 (en) 2002-06-12
MY116849A (en) 2004-04-30
HN1997000012A (es) 1997-06-26
HU226133B1 (en) 2008-05-28
IL124865A0 (en) 1999-01-26
SA97170578B1 (ar) 2006-01-28
IS1995B (is) 2005-03-15
CA2240777A1 (en) 1997-08-07
US6977302B2 (en) 2005-12-20
AU1598597A (en) 1997-08-22
NO323771B1 (no) 2007-07-02
ATE219089T1 (de) 2002-06-15
SK102298A3 (en) 1999-08-06
US20030144250A1 (en) 2003-07-31
NO983560D0 (no) 1998-08-03
NZ330654A (en) 1999-08-30
US6790957B2 (en) 2004-09-14
GB9602080D0 (en) 1996-04-03
AP678A (en) 1998-09-28
CO4761066A1 (es) 1999-04-27

Similar Documents

Publication Publication Date Title
YU2997A (sh) Derivati triazola korisni u terapiji
FI914723A0 (fi) 17b-substituerade 4-aza-5a-androstan -3-jon-derivat och foerfarande foer framstaellning av desamma.
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
PT1123276E (pt) N-(2-aril-propionil)-sulfonamidas e preparacoes farmaceuticas que as contem
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
DE69612003D1 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
NZ237884A (en) N-hydroxy-n-linolanyl (chromanyl or quinolinyl) alkyl urea and amide derivatives, preparation and pharmaceutical compositions thereof
EA200000728A1 (ru) Замещенные 2-бензиламино-2-фенилацетамидные соединения
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
CA2116829A1 (en) Use of a pregnane derivative
FR2739529B1 (fr) Composition fongicide comprenant un compose analogue de la strobilurine
EP1073447A4 (en) N1-MODIFIED GLYCOPEPTIDES
IT1258182B (it) Composizioni contenenti bafilomycina per l'inibizione di vacuolizzazione indotta da helicobacter pylori
ES2170377T3 (es) Composicion que contiene quitosana.
AU4461496A (en) The use of heterocyclic compounds as antioxidants, radical scavengers, fe2+ complexing agents, tissue- and/or neuroprotectants
TR200000753T2 (tr) Mukabil antifungal ajan için prodrog olarak tetrahidrofuran fosfat ve hidroksi esterleri.
ECSP972013A (es) Derivados de triazol utiles en terapia
PT777471E (pt) Metodo de inibicao da biosintese de leucotrieno
ES2101620A1 (es) Nuevo compuesto derivado del cromeno.
DK1200099T3 (da) Synergistisk sammensætning indeholdende daunorubicinderivater og antimetabolitforbindelser